Atazanavir Sulfate
2 NDCs across 1 manufacturer|2 Generic,0 Brand
Atazanavir Sulfate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 20, 2003, and the first generic was approved Apr 22, 2014. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $5 million on Atazanavir Sulfate across 11,000 claims for 1,577 beneficiaries.
Atazanavir Sulfate is available as 2 NDCs from 1 manufacturer (2 generic, 0 brand), with NADAC prices from $1.11 to $2.23 per EA — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
2G / 0B
Manufacturers
1
competing in market
Price Spread
$1.11 – $2.23
per EA
7d Activity
avg -3.6% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Teva Pharmaceuticals USA Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Protease Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ATAZANAVIR SULFATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ATAZANAVIR SULFATE 300 MG CAP | $2.2264 per EA | -3.56% |
ATAZANAVIR SULFATE 200 MG CAP | $1.1087 per EA | — |
Frequently Asked Questions
What is Atazanavir Sulfate used to treat?
Atazanavir Sulfate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
When did Atazanavir Sulfate become available as a generic?
FDA approved the first generic Atazanavir Sulfate (ANDA) on Apr 22, 2014. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Atazanavir Sulfate?
In 2024, Medicare Part D spent $5 million on Atazanavir Sulfate across 11,000 claims for 1,577 beneficiaries.
How many Atazanavir Sulfate products are on the market?
The Atazanavir Sulfate drug market contains 2 NDCs from 1 manufacturer — 2 generic and 0 brand products.
What is the price range for Atazanavir Sulfate?
NADAC reference prices for Atazanavir Sulfate range from $1.1087 to $2.2264 per EA — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Atazanavir Sulfate?
1 manufacturer lists Atazanavir Sulfate in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (2).
How has the price of Atazanavir Sulfate changed recently?
Over the past 7 days, 0 Atazanavir Sulfate NDCs rose and 1 fell, with a market-wide average change of -3.6%.